Human poly(ADP-ribose) polymerase gene. Cloning of the promoter region. 1990

Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
Department of Medical Chemistry, Kochi Medical School, Japan.

The promoter region of the poly(ADP-ribose) polymerase gene has been isolated using a Sau3AI genomic library derived from human leukocyte. It lacks typical transcriptional regulatory elements such as TATA and CAAT boxes, but it contains two potential Sp1 binding sites and three putative AP-2 binding elements. The region up to nucleotide position-99 in relation to the predominant transcriptional initiation site exhibits promoter activity as judged by chloramphenicol acetyltransferase assay and the activity is enhanced both by cAMP and by phorbol ester. Northern blot and Western blot analyses have revealed that expression of the polymerase gene is also stimulated by both of these compounds in cultured HeLa cells. Southern blot hybridization of genomic DNA separately digested with various endonucleases gives a discrete single band in each case when the 5'-untranslated region of the polymerase cDNA is used as a probe. These results indicate that poly(ADP-ribose) polymerase is encoded by a unique gene whose expression is regulable by cAMP and by phorbol ester.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
May 1999, Genomics,
Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
March 1987, Proceedings of the National Academy of Sciences of the United States of America,
Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
March 1990, Biochemical and biophysical research communications,
Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
February 2000, Atherosclerosis,
Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
November 1998, Plant physiology,
Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
July 1999, Oncogene,
Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
March 2003, Arthritis and rheumatism,
Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
December 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
June 2015, The Journal of pharmacology and experimental therapeutics,
Y Yokoyama, and T Kawamoto, and Y Mitsuuchi, and T Kurosaki, and K Toda, and H Ushiro, and M Terashima, and H Sumimoto, and I Kuribayashi, and Y Yamamoto
February 2003, Current medicinal chemistry,
Copied contents to your clipboard!